TO evaluate the safety and efficacy of Unani medicines (Funduq and Shaqaqul) in the management of Male Infertility.

Phase 2

• Conditions: Health Condition 1: null- Oligoasthenospermia with special reference to male infertility

• Registration Number: CTRI/2017/08/009389
• Lead Sponsor: Govt Nizamia Tibbi College

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Closed to Recruitment of Participants
• Sex: Not specified
• Target Recruitment: 30

Inclusion Criteria

1.Married males with established Oligoasthenospermia.

2.Male partner with at least one year infertility and having availability of the female partners clinical fertility data.

3.Infertile couples who are living together for more than one year and had regular unprotected sexual intercourse.

4.No history of receiving andrologically effective treatment for a minimum of three months.

Exclusion Criteria

1.Those with developmental anomalies of genito-urinary system.

2.Subjects with azoospermia and sperm motility less than five percent.

3.Patients who are not willing to give a written consent.

4.Male partners who are smokers,alcoholics,and the people who get exposed to extreme heat.

5.Patients with specific and chronic disorders and having impaired hepatic and renal functions

Study & Design

• Study Type: Interventional
• Study Design: Not specified